CEO Letters
Overview
Mission
Leadership
Management Team
Board of Directors
Corporate Compliance
Corporate Governance
Products
Endari
Pipeline
Research Publications
Diverticulosis
Cell Sheet Engineering
News
Press Releases
Media Contacts
Media Kit
Investors
Career
Contact Us
News & Events
Investors
Investors
Overview
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Company Info
Overview
Management Team
Presentations
Contacts
FAQ
Financial Info
Overview
Financial Results
Income Statement
Balance Sheet
Cash Flow
Stock Data
Quote
Charts
Historical Data
SEC Filings
Overview
All SEC Filings
Annual Reports
Quarterly Reports
Section 16 Filings
Pre-merger Emmaus Life Science SEC Filings
Governance
Overview
Board of Directors
Board Committees
Governance Documents
News & Events
Overview
Press Releases
IR Calendar
Email Alerts
Recent News
View All News
Emmaus Life Sciences Receives FDA Approval for Endari® Label Enhancements
Jun 26, 2025 9:30am EDT
Emmaus Life Sciences Reports Quarterly Financial Results
May 15, 2025 4:30pm EDT
Email Alerts
Sign up for email alerts for Press Releases & SEC Filings
Sign Up
Email Alerts
Tear Sheet
Contacts
RSS News Feed
